|
Eribulin
|
|
3
|
1192
|
12 April 2024
|
|
Atrophy
|
|
11
|
991
|
31 March 2024
|
|
Is Enhertu available in the UK, on the NHS
|
|
20
|
1709
|
18 March 2024
|
|
Have you recieved elacestrant (orserdu)?
|
|
0
|
430
|
18 March 2024
|
|
Xgeva (denosumab) and low White blood count
|
|
1
|
522
|
16 March 2024
|
|
Change of treatment - PICC or central line
|
|
12
|
497
|
16 March 2024
|
|
CA15-3 marker
|
|
7
|
1337
|
16 March 2024
|
|
Weight gain in short space of time ?
|
|
5
|
985
|
13 March 2024
|
|
Tamoxifen Brand Change
|
|
3
|
466
|
10 March 2024
|
|
Terrible balance problem
|
|
7
|
794
|
8 February 2024
|
|
Cancer Research Awareness
|
|
0
|
270
|
4 February 2024
|
|
Xeloda and bone recurrence
|
|
3
|
524
|
31 January 2024
|
|
Atezolizumab and Nab-paclitaxel (Abraxane) experience
|
|
5
|
1395
|
30 January 2024
|
|
About to start Trodelvy, any information please
|
|
6
|
3777
|
28 January 2024
|
|
Xeloda delay
|
|
13
|
737
|
21 January 2024
|
|
The dreaded canula
|
|
12
|
750
|
11 January 2024
|
|
Sacituzumab govitecan (Trodelvy)
|
|
3
|
1047
|
11 January 2024
|
|
HER2-low trastuzumab deruxtecan (Enhertu)
|
|
1
|
1603
|
1 January 2024
|
|
Covid 19
|
|
7
|
728
|
31 December 2023
|
|
Ribociclib dose reduced
|
|
7
|
744
|
29 December 2023
|
|
Xeloda dosage
|
|
5
|
612
|
19 December 2023
|
|
Letrozole advantages
|
|
12
|
1261
|
17 December 2023
|
|
Long story and MRI advice
|
|
5
|
1062
|
4 December 2023
|
|
Wbr
|
|
2
|
403
|
27 November 2023
|
|
Nearly 4 years in and brain mets. Please help
|
|
363
|
12915
|
9 November 2023
|
|
Talazoparib (Talzenna)
|
|
1
|
832
|
7 November 2023
|
|
A preference of Mastectomy Versus Lumpectomy
|
|
20
|
2193
|
28 October 2023
|
|
Serious immunotherapy adverse event - Pembrolizumab
|
|
3
|
704
|
26 October 2023
|
|
News on Research
|
|
1
|
670
|
25 October 2023
|
|
Hair regrowth after wbrt
|
|
1
|
498
|
24 October 2023
|